These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4044480)

  • 1. A trial of glucagon in fulminant hepatitis.
    Narendranathan M; Nandini KK; Balakrishnan V
    J Assoc Physicians India; 1985 Mar; 33(3):219-20. PubMed ID: 4044480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatic regeneration factor in fulminent hepatitis and its dynamic changes].
    Okita K; Matsuda A; Handa T; Esaki T; Oda M; Takemoto T
    Nihon Rinsho; 1982; 40(4):837-42. PubMed ID: 6178860
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma exchange in patients with fulminant hepatic failure.
    Buckner CD; Clift RA; Volwiler W; Donohue DM; Burnell JM; Saunders FC; Thomas ED
    Arch Intern Med; 1973 Oct; 132(4):487-92. PubMed ID: 4742403
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of steroid therapy in massive hepatic necrosis.
    Ware AJ; Jones RE; Shorey JW; Combes B
    Am J Gastroenterol; 1974 Aug; 62(2):130-3. PubMed ID: 4606110
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term therapy of liver diseases].
    Markoff N
    Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor alpha levels.
    Tomiya T; Fujiwara K
    Hepatology; 1996 Feb; 23(2):253-7. PubMed ID: 8591849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of insulin and glucagon on fulminant murine hepatitis.
    Farivar M; Wands JR; Isselbacher KJ; Bucher NL
    N Engl J Med; 1976 Dec; 295(27):1517-9. PubMed ID: 995158
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucocorticotherapy in hepatic diseases].
    Boroń P; Borzuchowska A; Modzelewski T
    Przegl Lek; 1970; 26(10):753-5. PubMed ID: 5484242
    [No Abstract]   [Full Text] [Related]  

  • 9. [Corticosteroid therapy in hepatic diseases].
    Mazzacca G
    Recenti Prog Med; 1967 Jul; 43(1):51-70. PubMed ID: 4302862
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin and glucagon infusion in the treatment of liver failure.
    Jaspan JB; Landau RL; Schneider J
    Arch Intern Med; 1984 Oct; 144(10):2075-8. PubMed ID: 6385900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure.
    Harrison PM; Hughes RD; Forbes A; Portmann B; Alexander GJ; Williams R
    J Hepatol; 1990 May; 10(3):332-6. PubMed ID: 2195108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine (Imuran) in treatment of hepatic failure.
    Deitcher KA; Trey C
    Pediatrics; 1970 Jul; 46(1):161. PubMed ID: 5423453
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reflections on prednisone therapy of patients with liver diseases].
    Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
    [No Abstract]   [Full Text] [Related]  

  • 14. How trophic are the hepatotrophic factors?
    Abraham P; Mehta PJ; Sainani GS
    J Assoc Physicians India; 1985 Mar; 33(3):200-1. PubMed ID: 3900027
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current anatomo-pathological and developmental aspects of viral hepatitis].
    Orcel L; Smadja A; Grynblat A; Scotto J
    Ann Anat Pathol (Paris); 1970; 15(1):61-104. PubMed ID: 5443948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of glucocorticoids on the morphological picture of the liver in the course of hepatic coma caused by viral hepatitis].
    Kurasz S; Nowak HF; Boroń P; Szpakowicz T
    Patol Pol; 1977; 28(3):389-93. PubMed ID: 927925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
    Busin S; Micheli PL; Sovera A
    Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971
    [No Abstract]   [Full Text] [Related]  

  • 18. Portal venous "goodies" and fulminant viral hepatitis.
    Sherlock S
    N Engl J Med; 1976 Dec; 295(27):1535-6. PubMed ID: 995164
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advances in the treatment of liver disease].
    Neumayr A
    Wien Med Wochenschr; 1973 Oct; (40):577-82. PubMed ID: 4131665
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid.
    Summerskill WH; Thorsell F; Feinberg JH; Aldrete JS
    Gastroenterology; 1968 Jan; 54(1):20-6. PubMed ID: 5635434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.